Aktis Oncology, Inc. (AKTS) has 4 SEC Form 4 insider filings on record in the last 90 days. Most recent filing: July 21, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 21, 2026 filed July 20, 2026 | Herrmann Ken Director | $118,886 | 14,568 | 0% | No | |
|
|
||||||
| July 20, 2026 filed July 17, 2026 | Herrmann Ken Director | $77,013 | 9,195 | 0% | No | |
|
|
||||||
| July 10, 2026 filed July 8, 2026 | Ron-Bigger Shulamit Chief Operating Officer | $1,204,558 | 150,000 | 0% | No | |
|
|
||||||
| July 10, 2026 filed July 8, 2026 | Czibere Akos Chief Medical Officer | $1,141,201 | 150,000 | 0% | No | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free